APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ovulation Induction

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ovulation Induction Market Outlook and Growth Opportunities 2026

Report ID 174021310430 December 2025213 pages

Choose your research edition.

Industry ResearchOvulation Induction Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Ovulation Induction Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Ovulation Induction Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ovulation Induction Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Ovulation Induction Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Ovulation Induction market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ovulation Induction is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ovulation Induction is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ovulation Induction is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ovulation Induction market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ovulation Induction market include Takeda, Sanofi, Merck & Co. Inc, AbbVie, AstraZeneca, Unichem Laboratories, Teva Pharmaceuticals USA, Inc, TerSera Therapeutics and Techwell, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Ovulation Induction market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ovulation Induction and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ovulation Induction revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Ovulation Induction market.

Ovulation Induction Segment by Company

Takeda

Sanofi

Merck & Co. Inc

AbbVie

AstraZeneca

Unichem Laboratories

Teva Pharmaceuticals USA, Inc

TerSera Therapeutics

Techwell

Sun Pharmaceutical

Pharmascience Inc

Par pharmaceutical inc

Pacific Pharmaceuticals

LIVZON

Ipsen

IBSA

IBM Micromedex

Gedeon Richter

Fresenius Kabi

Ferring

Endo

EMD Serono Inc

Emcure Pharmaceuticals Ltd.

Cosette Pharmaceuticals, Inc

Bristol Myers Squibb

Ovulation Induction Segment by Type

Follicle Stimulating Hormone

Clomiphene Citrate

Human Menopausal Gonadotropin

Human Chorionic Gonadotropin

Others

Ovulation Induction Segment by Application

Clinic

Hospital

Medical Institution

Ovulation Induction Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Ovulation Induction status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Ovulation Induction key companies, revenue, market share, and recent developments.

3. To split the Ovulation Induction breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Ovulation Induction market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ovulation Induction significant trends, drivers, influence factors in global and regions.

6. To analyze Ovulation Induction competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ovulation Induction market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ovulation Induction and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ovulation Induction.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ovulation Induction industry.

Chapter 3: Detailed analysis of Ovulation Induction company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Ovulation Induction in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Ovulation Induction in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ovulation Induction Industry Trends Table 2. Ovulation Induction Industry Drivers Table 3. Ovulation Induction Industry Opportunities and Challenges Table 4. Ovulation Induction Industry Restraints Table 5. Global Ovulation Induction Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ovulation Induction Revenue Share by Company (2021-2026) Table 7. Global Ovulation Induction Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Ovulation Induction Key Company Manufacturing Base & Headquarters Table 9. Global Ovulation Induction Company, Product Type & Application Table 10. Global Ovulation Induction Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Ovulation Induction by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Follicle Stimulating Hormone Table 15. Significant Companies of Clomiphene Citrate Table 16. Significant Companies of Human Menopausal Gonadotropin Table 17. Significant Companies of Human Chorionic Gonadotropin Table 18. Significant Companies of Others Table 19. Global Ovulation Induction Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Ovulation Induction Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Ovulation Induction Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Ovulation Induction Sales Value Share by Type (2021-2026) Table 23. Global Ovulation Induction Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Clinic Table 25. Significant Companies of Hospital Table 26. Significant Companies of Medical Institution Table 27. Global Ovulation Induction Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Ovulation Induction Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Ovulation Induction Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Ovulation Induction Sales Value Share by Application (2021-2026) Table 31. Global Ovulation Induction Sales Value Share by Application (2027-2032) Table 32. Global Ovulation Induction Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Ovulation Induction Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Ovulation Induction Sales Value Share by Region (2021-2026) Table 35. Global Ovulation Induction Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Ovulation Induction Sales Value Share by Region (2027-2032) Table 37. Global Ovulation Induction Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Ovulation Induction Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Ovulation Induction Sales Value Market Share by Country (2021-2026) Table 40. Global Ovulation Induction Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Ovulation Induction Sales Value Market Share by Country (2027-2032) Table 42. Takeda Company Information Table 43. Takeda Business Overview Table 44. Takeda Ovulation Induction Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. Takeda Ovulation Induction Product Portfolio Table 46. Takeda Recent Development Table 47. Sanofi Company Information Table 48. Sanofi Business Overview Table 49. Sanofi Ovulation Induction Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Sanofi Ovulation Induction Product Portfolio Table 51. Sanofi Recent Development Table 52. Merck & Co. Inc Company Information Table 53. Merck & Co. Inc Business Overview Table 54. Merck & Co. Inc Ovulation Induction Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Merck & Co. Inc Ovulation Induction Product Portfolio Table 56. Merck & Co. Inc Recent Development Table 57. AbbVie Company Information Table 58. AbbVie Business Overview Table 59. AbbVie Ovulation Induction Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. AbbVie Ovulation Induction Product Portfolio Table 61. AbbVie Recent Development Table 62. AstraZeneca Company Information Table 63. AstraZeneca Business Overview Table 64. AstraZeneca Ovulation Induction Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. AstraZeneca Ovulation Induction Product Portfolio Table 66. AstraZeneca Recent Development Table 67. Unichem Laboratories Company Information Table 68. Unichem Laboratories Business Overview Table 69. Unichem Laboratories Ovulation Induction Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Unichem Laboratories Ovulation Induction Product Portfolio Table 71. Unichem Laboratories Recent Development Table 72. Teva Pharmaceuticals USA, Inc Company Information Table 73. Teva Pharmaceuticals USA, Inc Business Overview Table 74. Teva Pharmaceuticals USA, Inc Ovulation Induction Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Teva Pharmaceuticals USA, Inc Ovulation Induction Product Portfolio Table 76. Teva Pharmaceuticals USA, Inc Recent Development Table 77. TerSera Therapeutics Company Information Table 78. TerSera Therapeutics Business Overview Table 79. TerSera Therapeutics Ovulation Induction Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. TerSera Therapeutics Ovulation Induction Product Portfolio Table 81. TerSera Therapeutics Recent Development Table 82. Techwell Company Information Table 83. Techwell Business Overview Table 84. Techwell Ovulation Induction Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Techwell Ovulation Induction Product Portfolio Table 86. Techwell Recent Development Table 87. Sun Pharmaceutical Company Information Table 88. Sun Pharmaceutical Business Overview Table 89. Sun Pharmaceutical Ovulation Induction Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Sun Pharmaceutical Ovulation Induction Product Portfolio Table 91. Sun Pharmaceutical Recent Development Table 92. Pharmascience Inc Company Information Table 93. Pharmascience Inc Business Overview Table 94. Pharmascience Inc Ovulation Induction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Pharmascience Inc Ovulation Induction Product Portfolio Table 96. Pharmascience Inc Recent Development Table 97. Par pharmaceutical inc Company Information Table 98. Par pharmaceutical inc Business Overview Table 99. Par pharmaceutical inc Ovulation Induction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Par pharmaceutical inc Ovulation Induction Product Portfolio Table 101. Par pharmaceutical inc Recent Development Table 102. Pacific Pharmaceuticals Company Information Table 103. Pacific Pharmaceuticals Business Overview Table 104. Pacific Pharmaceuticals Ovulation Induction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Pacific Pharmaceuticals Ovulation Induction Product Portfolio Table 106. Pacific Pharmaceuticals Recent Development Table 107. LIVZON Company Information Table 108. LIVZON Business Overview Table 109. LIVZON Ovulation Induction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. LIVZON Ovulation Induction Product Portfolio Table 111. LIVZON Recent Development Table 112. Ipsen Company Information Table 113. Ipsen Business Overview Table 114. Ipsen Ovulation Induction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Ipsen Ovulation Induction Product Portfolio Table 116. Ipsen Recent Development Table 117. IBSA Company Information Table 118. IBSA Business Overview Table 119. IBSA Ovulation Induction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. IBSA Ovulation Induction Product Portfolio Table 121. IBSA Recent Development Table 122. IBM Micromedex Company Information Table 123. IBM Micromedex Business Overview Table 124. IBM Micromedex Ovulation Induction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. IBM Micromedex Ovulation Induction Product Portfolio Table 126. IBM Micromedex Recent Development Table 127. Gedeon Richter Company Information Table 128. Gedeon Richter Business Overview Table 129. Gedeon Richter Ovulation Induction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Gedeon Richter Ovulation Induction Product Portfolio Table 131. Gedeon Richter Recent Development Table 132. Fresenius Kabi Company Information Table 133. Fresenius Kabi Business Overview Table 134. Fresenius Kabi Ovulation Induction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Fresenius Kabi Ovulation Induction Product Portfolio Table 136. Fresenius Kabi Recent Development Table 137. Ferring Company Information Table 138. Ferring Business Overview Table 139. Ferring Ovulation Induction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Ferring Ovulation Induction Product Portfolio Table 141. Ferring Recent Development Table 142. Endo Company Information Table 143. Endo Business Overview Table 144. Endo Ovulation Induction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Endo Ovulation Induction Product Portfolio Table 146. Endo Recent Development Table 147. EMD Serono Inc Company Information Table 148. EMD Serono Inc Business Overview Table 149. EMD Serono Inc Ovulation Induction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. EMD Serono Inc Ovulation Induction Product Portfolio Table 151. EMD Serono Inc Recent Development Table 152. Emcure Pharmaceuticals Ltd. Company Information Table 153. Emcure Pharmaceuticals Ltd. Business Overview Table 154. Emcure Pharmaceuticals Ltd. Ovulation Induction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Emcure Pharmaceuticals Ltd. Ovulation Induction Product Portfolio Table 156. Emcure Pharmaceuticals Ltd. Recent Development Table 157. Cosette Pharmaceuticals, Inc Company Information Table 158. Cosette Pharmaceuticals, Inc Business Overview Table 159. Cosette Pharmaceuticals, Inc Ovulation Induction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Cosette Pharmaceuticals, Inc Ovulation Induction Product Portfolio Table 161. Cosette Pharmaceuticals, Inc Recent Development Table 162. Bristol Myers Squibb Company Information Table 163. Bristol Myers Squibb Business Overview Table 164. Bristol Myers Squibb Ovulation Induction Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Bristol Myers Squibb Ovulation Induction Product Portfolio Table 166. Bristol Myers Squibb Recent Development Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Ovulation Induction Product Image Figure 2. Global Ovulation Induction Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ovulation Induction Market Size (2021-2032) & (US$ Million) Figure 4. Global Ovulation Induction Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Follicle Stimulating Hormone Image Figure 8. Clomiphene Citrate Image Figure 9. Human Menopausal Gonadotropin Image Figure 10. Human Chorionic Gonadotropin Image Figure 11. Others Image Figure 12. Global Ovulation Induction Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Ovulation Induction Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Ovulation Induction Sales Value Share by Type (2021-2032) Figure 15. Clinic Image Figure 16. Hospital Image Figure 17. Medical Institution Image Figure 18. Global Ovulation Induction Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Ovulation Induction Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Ovulation Induction Sales Value Share by Application (2021-2032) Figure 21. Global Ovulation Induction Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Ovulation Induction Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Ovulation Induction Sales Value (2021-2032) & (US$ Million) Figure 24. North America Ovulation Induction Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Ovulation Induction Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Ovulation Induction Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Ovulation Induction Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Ovulation Induction Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Ovulation Induction Sales Value (2021-2032) & (US$ Million) Figure 30. South America Ovulation Induction Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Ovulation Induction Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Ovulation Induction Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Ovulation Induction Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Ovulation Induction Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Ovulation Induction Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Follicle Stimulating Hormone
  • Clomiphene Citrate
  • Human Menopausal Gonadotropin
  • Human Chorionic Gonadotropin
  • Others
Applications
  • Clinic
  • Hospital
  • Medical Institution
Companies covered
  • Takeda
  • Sanofi
  • Merck & Co. Inc
  • AbbVie
  • AstraZeneca
  • Unichem Laboratories
  • Teva Pharmaceuticals USA, Inc
  • TerSera Therapeutics
  • Techwell
  • Sun Pharmaceutical
  • Pharmascience Inc
  • Par pharmaceutical inc
  • Pacific Pharmaceuticals
  • LIVZON
  • Ipsen
  • IBSA
  • IBM Micromedex
  • Gedeon Richter
  • Fresenius Kabi
  • Ferring
  • Endo
  • EMD Serono Inc
  • Emcure Pharmaceuticals Ltd.
  • Cosette Pharmaceuticals, Inc
  • Bristol Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Ovulation Induction Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Ovulation Induction Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Ovulation Induction Market Dynamics
  1. 2.1 Ovulation Induction Industry Trends
  2. 2.2 Ovulation Induction Industry Drivers
  3. 2.3 Ovulation Induction Industry Opportunities and Challenges
  4. 2.4 Ovulation Induction Industry Restraints
3 Ovulation Induction Market by Company
  1. 3.1 Global Ovulation Induction Company Revenue Ranking in 2025
  2. 3.2 Global Ovulation Induction Revenue by Company (2021-2026)
  3. 3.3 Global Ovulation Induction Company Ranking (2024-2026)
  4. 3.4 Global Ovulation Induction Company Manufacturing Base and Headquarters
  5. 3.5 Global Ovulation Induction Company Product Type and Application
  6. 3.6 Global Ovulation Induction Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Ovulation Induction Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Ovulation Induction Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Ovulation Induction Market by Type
  1. 4.1 Ovulation Induction Type Introduction
  2. 4.1.1 Follicle Stimulating Hormone
  3. 4.1.2 Clomiphene Citrate
  4. 4.1.3 Human Menopausal Gonadotropin
  5. 4.1.4 Human Chorionic Gonadotropin
  6. 4.1.5 Others
  7. 4.2 Global Ovulation Induction Sales Value by Type
  8. 4.2.1 Global Ovulation Induction Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Ovulation Induction Sales Value by Type (2021-2032)
  10. 4.2.3 Global Ovulation Induction Sales Value Share by Type (2021-2032)
5 Ovulation Induction Market by Application
  1. 5.1 Ovulation Induction Application Introduction
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Medical Institution
  5. 5.2 Global Ovulation Induction Sales Value by Application
  6. 5.2.1 Global Ovulation Induction Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ovulation Induction Sales Value by Application (2021-2032)
  8. 5.2.3 Global Ovulation Induction Sales Value Share by Application (2021-2032)
6 Ovulation Induction Regional Value Analysis
  1. 6.1 Global Ovulation Induction Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ovulation Induction Sales Value by Region (2021-2032)
  3. 6.2.1 Global Ovulation Induction Sales Value by Region: 2021-2026
  4. 6.2.2 Global Ovulation Induction Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Ovulation Induction Sales Value (2021-2032)
  7. 6.3.2 North America Ovulation Induction Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Ovulation Induction Sales Value (2021-2032)
  10. 6.4.2 Europe Ovulation Induction Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Ovulation Induction Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Ovulation Induction Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Ovulation Induction Sales Value (2021-2032)
  16. 6.6.2 South America Ovulation Induction Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Ovulation Induction Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Ovulation Induction Sales Value Share by Country, 2025 VS 2032
7 Ovulation Induction Country-level Value Analysis
  1. 7.1 Global Ovulation Induction Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ovulation Induction Sales Value by Country (2021-2032)
  3. 7.2.1 Global Ovulation Induction Sales Value by Country (2021-2026)
  4. 7.2.2 Global Ovulation Induction Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Ovulation Induction Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Ovulation Induction Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Ovulation Induction Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Ovulation Induction Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Ovulation Induction Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Ovulation Induction Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Ovulation Induction Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Ovulation Induction Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Ovulation Induction Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Ovulation Induction Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Ovulation Induction Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Ovulation Induction Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Ovulation Induction Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Ovulation Induction Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Ovulation Induction Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Ovulation Induction Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Ovulation Induction Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Ovulation Induction Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Ovulation Induction Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Ovulation Induction Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Ovulation Induction Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Ovulation Induction Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Ovulation Induction Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Ovulation Induction Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Ovulation Induction Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Ovulation Induction Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Ovulation Induction Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Ovulation Induction Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Ovulation Induction Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Ovulation Induction Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Ovulation Induction Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Ovulation Induction Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Ovulation Induction Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Ovulation Induction Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Ovulation Induction Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Merck & Co. Inc
  14. 8.3.1 Merck & Co. Inc Company Information
  15. 8.3.2 Merck & Co. Inc Business Overview
  16. 8.3.3 Merck & Co. Inc Ovulation Induction Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck & Co. Inc Ovulation Induction Product Portfolio
  18. 8.3.5 Merck & Co. Inc Recent Developments
  19. 8.4 AbbVie
  20. 8.4.1 AbbVie Company Information
  21. 8.4.2 AbbVie Business Overview
  22. 8.4.3 AbbVie Ovulation Induction Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AbbVie Ovulation Induction Product Portfolio
  24. 8.4.5 AbbVie Recent Developments
  25. 8.5 AstraZeneca
  26. 8.5.1 AstraZeneca Company Information
  27. 8.5.2 AstraZeneca Business Overview
  28. 8.5.3 AstraZeneca Ovulation Induction Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AstraZeneca Ovulation Induction Product Portfolio
  30. 8.5.5 AstraZeneca Recent Developments
  31. 8.6 Unichem Laboratories
  32. 8.6.1 Unichem Laboratories Company Information
  33. 8.6.2 Unichem Laboratories Business Overview
  34. 8.6.3 Unichem Laboratories Ovulation Induction Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Unichem Laboratories Ovulation Induction Product Portfolio
  36. 8.6.5 Unichem Laboratories Recent Developments
  37. 8.7 Teva Pharmaceuticals USA, Inc
  38. 8.7.1 Teva Pharmaceuticals USA, Inc Company Information
  39. 8.7.2 Teva Pharmaceuticals USA, Inc Business Overview
  40. 8.7.3 Teva Pharmaceuticals USA, Inc Ovulation Induction Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Teva Pharmaceuticals USA, Inc Ovulation Induction Product Portfolio
  42. 8.7.5 Teva Pharmaceuticals USA, Inc Recent Developments
  43. 8.8 TerSera Therapeutics
  44. 8.8.1 TerSera Therapeutics Company Information
  45. 8.8.2 TerSera Therapeutics Business Overview
  46. 8.8.3 TerSera Therapeutics Ovulation Induction Revenue and Gross Margin (2021-2026)
  47. 8.8.4 TerSera Therapeutics Ovulation Induction Product Portfolio
  48. 8.8.5 TerSera Therapeutics Recent Developments
  49. 8.9 Techwell
  50. 8.9.1 Techwell Company Information
  51. 8.9.2 Techwell Business Overview
  52. 8.9.3 Techwell Ovulation Induction Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Techwell Ovulation Induction Product Portfolio
  54. 8.9.5 Techwell Recent Developments
  55. 8.10 Sun Pharmaceutical
  56. 8.10.1 Sun Pharmaceutical Company Information
  57. 8.10.2 Sun Pharmaceutical Business Overview
  58. 8.10.3 Sun Pharmaceutical Ovulation Induction Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sun Pharmaceutical Ovulation Induction Product Portfolio
  60. 8.10.5 Sun Pharmaceutical Recent Developments
  61. 8.11 Pharmascience Inc
  62. 8.11.1 Pharmascience Inc Company Information
  63. 8.11.2 Pharmascience Inc Business Overview
  64. 8.11.3 Pharmascience Inc Ovulation Induction Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pharmascience Inc Ovulation Induction Product Portfolio
  66. 8.11.5 Pharmascience Inc Recent Developments
  67. 8.12 Par pharmaceutical inc
  68. 8.12.1 Par pharmaceutical inc Company Information
  69. 8.12.2 Par pharmaceutical inc Business Overview
  70. 8.12.3 Par pharmaceutical inc Ovulation Induction Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Par pharmaceutical inc Ovulation Induction Product Portfolio
  72. 8.12.5 Par pharmaceutical inc Recent Developments
  73. 8.13 Pacific Pharmaceuticals
  74. 8.13.1 Pacific Pharmaceuticals Company Information
  75. 8.13.2 Pacific Pharmaceuticals Business Overview
  76. 8.13.3 Pacific Pharmaceuticals Ovulation Induction Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Pacific Pharmaceuticals Ovulation Induction Product Portfolio
  78. 8.13.5 Pacific Pharmaceuticals Recent Developments
  79. 8.14 LIVZON
  80. 8.14.1 LIVZON Company Information
  81. 8.14.2 LIVZON Business Overview
  82. 8.14.3 LIVZON Ovulation Induction Revenue and Gross Margin (2021-2026)
  83. 8.14.4 LIVZON Ovulation Induction Product Portfolio
  84. 8.14.5 LIVZON Recent Developments
  85. 8.15 Ipsen
  86. 8.15.1 Ipsen Company Information
  87. 8.15.2 Ipsen Business Overview
  88. 8.15.3 Ipsen Ovulation Induction Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Ipsen Ovulation Induction Product Portfolio
  90. 8.15.5 Ipsen Recent Developments
  91. 8.16 IBSA
  92. 8.16.1 IBSA Company Information
  93. 8.16.2 IBSA Business Overview
  94. 8.16.3 IBSA Ovulation Induction Revenue and Gross Margin (2021-2026)
  95. 8.16.4 IBSA Ovulation Induction Product Portfolio
  96. 8.16.5 IBSA Recent Developments
  97. 8.17 IBM Micromedex
  98. 8.17.1 IBM Micromedex Company Information
  99. 8.17.2 IBM Micromedex Business Overview
  100. 8.17.3 IBM Micromedex Ovulation Induction Revenue and Gross Margin (2021-2026)
  101. 8.17.4 IBM Micromedex Ovulation Induction Product Portfolio
  102. 8.17.5 IBM Micromedex Recent Developments
  103. 8.18 Gedeon Richter
  104. 8.18.1 Gedeon Richter Company Information
  105. 8.18.2 Gedeon Richter Business Overview
  106. 8.18.3 Gedeon Richter Ovulation Induction Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Gedeon Richter Ovulation Induction Product Portfolio
  108. 8.18.5 Gedeon Richter Recent Developments
  109. 8.19 Fresenius Kabi
  110. 8.19.1 Fresenius Kabi Company Information
  111. 8.19.2 Fresenius Kabi Business Overview
  112. 8.19.3 Fresenius Kabi Ovulation Induction Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Fresenius Kabi Ovulation Induction Product Portfolio
  114. 8.19.5 Fresenius Kabi Recent Developments
  115. 8.20 Ferring
  116. 8.20.1 Ferring Company Information
  117. 8.20.2 Ferring Business Overview
  118. 8.20.3 Ferring Ovulation Induction Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Ferring Ovulation Induction Product Portfolio
  120. 8.20.5 Ferring Recent Developments
  121. 8.21 Endo
  122. 8.21.1 Endo Company Information
  123. 8.21.2 Endo Business Overview
  124. 8.21.3 Endo Ovulation Induction Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Endo Ovulation Induction Product Portfolio
  126. 8.21.5 Endo Recent Developments
  127. 8.22 EMD Serono Inc
  128. 8.22.1 EMD Serono Inc Company Information
  129. 8.22.2 EMD Serono Inc Business Overview
  130. 8.22.3 EMD Serono Inc Ovulation Induction Revenue and Gross Margin (2021-2026)
  131. 8.22.4 EMD Serono Inc Ovulation Induction Product Portfolio
  132. 8.22.5 EMD Serono Inc Recent Developments
  133. 8.23 Emcure Pharmaceuticals Ltd.
  134. 8.23.1 Emcure Pharmaceuticals Ltd. Company Information
  135. 8.23.2 Emcure Pharmaceuticals Ltd. Business Overview
  136. 8.23.3 Emcure Pharmaceuticals Ltd. Ovulation Induction Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Emcure Pharmaceuticals Ltd. Ovulation Induction Product Portfolio
  138. 8.23.5 Emcure Pharmaceuticals Ltd. Recent Developments
  139. 8.24 Cosette Pharmaceuticals, Inc
  140. 8.24.1 Cosette Pharmaceuticals, Inc Company Information
  141. 8.24.2 Cosette Pharmaceuticals, Inc Business Overview
  142. 8.24.3 Cosette Pharmaceuticals, Inc Ovulation Induction Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Cosette Pharmaceuticals, Inc Ovulation Induction Product Portfolio
  144. 8.24.5 Cosette Pharmaceuticals, Inc Recent Developments
  145. 8.25 Bristol Myers Squibb
  146. 8.25.1 Bristol Myers Squibb Company Information
  147. 8.25.2 Bristol Myers Squibb Business Overview
  148. 8.25.3 Bristol Myers Squibb Ovulation Induction Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Bristol Myers Squibb Ovulation Induction Product Portfolio
  150. 8.25.5 Bristol Myers Squibb Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst